Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Pfizer Inc. (PFE)
Market Closed
2 Sep, 20:00
NYSE
All
(14)
DE
(6)
AT
(1)
CL
(1)
IT
(1)
MX
(1)
GB
(2)
CO
(1)
US
(1)
NYSE
Primary
LSE
XMEX
XSTU
XDUS
XSGO
XMUN
XHAN
XWBO
XETRA
BVC
XFRA
XMIL
CBOE
$
29.
02
+0.47
+1.6462%
$
159.36B
Market Cap
14.55
P/E Ratio
0.68%
Div Yield
39.26M
Volume
1.43
Eps
$
28.55
Previous Close
Investors:
TJD
DI
LC
+866
Watching
Watch
Add Transaction
Day Range
28.71
29.09
Year Range
23.58
29.09
Want to track
PFE
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
Pfizer Inc. (PFE) Statistics
Valuation metrics
Market Cap
159.36B
Enterprise value
221.57B
Trailing P/E (ttm)
36.95
Forward P/E
9.09
PEG ratio
-0.62
Price/Sales (ttm)
2.5
Price/Book (mrq)
1.87
Enterprise Value/Revenue
3.48
Enterprise Value/EBITDA
17.55
Overview
Shares outstanding
5.7B
Float
5.69B
Shares short
133.41M
% Held by insiders
0%
% Held by institutions
0.69%
Average volume (10 days)
32.73M
Average volume (90 days)
42.16M
Price summary
52-Week low
23.58
52-Week high
29.09
Beta
0.3
50-Day moving average
26.31
200-Day moving average
26.64
Dividends and splits
Forward annual dividend rate
1.72
Forward annual dividend yield
0.0664%
Trailing annual dividend rate
1.72
Trailing annual dividend yield
0.0615%
5-Year annual dividend yield
5.01%
Payout ratio
2.26
Dividend Date
1 Sep 2026
Ex-Dividend Date
24 Jul 2026
Last split factor
1,054:1,000
Last split Date
17 Nov 2020
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.07%
Operating margin
0.25%
Operational effectiveness
Return on assets
0.02%
Return on equity
0.05%
Income Statement
Revenue (ttm)
63.32B
Revenue per share (ttm)
11.18
Quarterly revenue growth (yoy)
0.05%
Gross profit (ttm)
47.36B
EBITDA
23.89B
Net income to common (ttm)
7.48B
Diluted EPS (ttm)
0.76
Quarterly earnings growth (yoy)
-0.09%
Balance Sheet
Total cash (mrq)
13.08B
Total cash per share (mrq)
2.05
Total debt (mrq)
64.73B
Total Debt/Equity (mrq)
0.74
Current ratio (mrq)
1.27%
Book value per share (mrq)
15
Cash Flow
Cash flow statement
11.98B
Levered free cash flow (LFCF)
12.38B